People are bad at staying focused. We’ve all had our minds wander when we try to concentrate on a task that requires paying close attention but isn’t all that engaging. But a new NIH-funded study suggests that one’s capacity to stay focused can improve with real-time feedback.
In an NIH-supported clinical trial comparing three drugs for diabetic macular edema (DME), Eylea (aflibercept) provided greater visual improvement, on average, than did Avastin (bevacizumab) or Lucentis (ranibizumab) when vision was 20/50 or worse at the start of the trial.
A class of medications long used to curb HIV infection shows promise as a therapy for age-related macular degeneration (AMD), suggest findings from an NIH-funded study.
News from NEI Grantees
- LSU Health New Orleans Makes Discovery Key to Preventing Blindness and Stroke Devastation Posted on March 9, 2015
- Results challenge conventional wisdom about where the brain begins processing visual information Posted on March 2, 2015
- Stem Cells from Wisdom Teeth Can Be Transformed into Corneal Cells–Could Potentially Be Used to Treat Corneal Scarring Posted on February 23, 2015
- Tufts University Researchers Identify Mechanism Involved in Causing Cataracts in Mice Posted on January 12, 2015
- New research unlocks a mystery of albinism Posted on December 16, 2014
- Patient’s Own Stem Cells Could Clear a Cloudy Cornea, Pitt Team Says Posted on December 10, 2014
- Elderly brains learn, but maybe too much Posted on November 26, 2014
- Stem Cells Have Potential to Repair Diseased Corneas September Posted on September 17, 2014
- New Glaucoma Culprit Is Found Posted on September 12, 2014
- View all News from NEI Grantees
Budget and Congress
The NEI budget is approximately $675 million (FY2014). The NEI budget requests are submitted to Congress with other NIH institutes as part of the President’s budget request in February. See our Congressional Justifications.